13F-HR filed by ORACLE INVESTMENT MANAGEMENT INC
ORACLE INVESTMENT MANAGEMENT INC filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-14, with 22 holding rows worth $166,870,674.
- Accession
- 0001085146-24-005974
- Filer
- CIK 1012622
- Filed
- 2024-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2024
A holdings report, 22 entries on the cover page, a total value of $166,870,674 stated on the cover page (in dollars after the unit check, H1), rows summing to $166,870,674 with VALUE read as dollars as filed, 13F file number 028-05592. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| GENEDX HOLDINGS CORP | 81663L200 | COM CL A | 1,045,768 | $44,382,394 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 705,250 | $35,241,343 | dollars as filed | |
| BIOHAVEN LTD | G1110E907 | COM | 302,700 | $15,125,919 | dollars as filed | call |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 749,487 | $13,550,725 | dollars as filed | |
| SPDR SERIES TRUST | 78464A900 | ST STR SP BIOT | 100,000 | $9,880,000 | dollars as filed | call |
| ARDELYX INC | 039697107 | COM | 1,369,200 | $9,433,788 | dollars as filed | |
| NOVAVAX INC | 670002901 | COM NEW | 534,600 | $6,751,998 | dollars as filed | call |
| QUIDELORTHO CORP COM | 219798105 | Stock | 118,291 | $5,394,070 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 535,558 | $4,070,241 | dollars as filed | |
| MYRIAD GENETICS INC | 62855J104 | COM | 134,500 | $3,683,955 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W907 | COM | 192,700 | $3,484,016 | dollars as filed | call |
| ARDELYX INC | 039697907 | COM | 430,200 | $2,964,078 | dollars as filed | call |
| FORIAN INC | 34630N106 | cs | 1,356,107 | $2,929,191 | dollars as filed | |
| EYEPOINT PHARMACEUTICALS INC | 30233G909 | CALL | 350,000 | $2,796,500 | dollars as filed | call |
| CAVAGROUPINC | 148929102 | STOK | 18,600 | $2,303,610 | dollars as filed | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 727,877 | $1,237,391 | dollars as filed | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 34,200 | $1,095,768 | dollars as filed | |
| Palantir Technologies Inc. Class A | 69608A108 | COM | 27,500 | $1,023,000 | dollars as filed | |
| PALANTIR TECHNOLOGIES INC | 69608A908 | CALL | 20,000 | $744,000 | dollars as filed | call |
| BIOGEN INC COM | 09062X103 | Stock | 2,412 | $467,542 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 32,500 | $259,675 | dollars as filed | |
| BIODESIX INC | 09075X108 | COM | 28,916 | $51,470 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-24-005974 | this filing | 2024-11-14 | acceptance time not in the bulk data set |